315 related articles for article (PubMed ID: 22108032)
1. Rotavirus vaccines: update on global impact and future priorities.
Yen C; Tate JE; Patel MM; Cortese MM; Lopman B; Fleming J; Lewis K; Jiang B; Gentsch J; Steele D; Parashar UD
Hum Vaccin; 2011 Dec; 7(12):1282-90. PubMed ID: 22108032
[TBL] [Abstract][Full Text] [Related]
2. Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward.
Parashar UD; Johnson H; Steele AD; Tate JE
Clin Infect Dis; 2016 May; 62 Suppl 2():S91-5. PubMed ID: 27059361
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
[TBL] [Abstract][Full Text] [Related]
4. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
Enane LA; Gastañaduy PA; Goldfarb DM; Pernica JM; Mokomane M; Moorad B; Masole L; Tate JE; Parashar UD; Steenhoff AP
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S168-74. PubMed ID: 27059352
[TBL] [Abstract][Full Text] [Related]
5. Current status of rotavirus vaccines.
Wang CM; Chen SC; Chen KT
World J Pediatr; 2015 Nov; 11(4):300-8. PubMed ID: 26454434
[TBL] [Abstract][Full Text] [Related]
6. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
[TBL] [Abstract][Full Text] [Related]
7. Global impact of rotavirus vaccines.
Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
[TBL] [Abstract][Full Text] [Related]
8. A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects.
Buchy P; Chen J; Zhang XH; Benninghoff B; Lee C; Bibera GL
Expert Rev Vaccines; 2021 Dec; 20(12):1499-1514. PubMed ID: 33275065
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.
Bresee JS; Hummelman E; Nelson EA; Glass RI
J Infect Dis; 2005 Sep; 192 Suppl 1():S1-5. PubMed ID: 16088790
[No Abstract] [Full Text] [Related]
10. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
[TBL] [Abstract][Full Text] [Related]
11. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
12. The control of rotavirus gastroenteritis in the United States.
Glass RI; Parashar U; Patel M; Tate J; Jiang B; Gentsch J
Trans Am Clin Climatol Assoc; 2012; 123():36-52; discussion 53. PubMed ID: 23303967
[TBL] [Abstract][Full Text] [Related]
13. Prospects for routine childhood vaccination against rotavirus in India.
Parashar U; Tate J; Arora R; Kang G
Natl Med J India; 2012; 25(5):257-60. PubMed ID: 23448622
[No Abstract] [Full Text] [Related]
14. Rotavirus vaccination within the South African Expanded Programme on Immunisation.
Seheri LM; Page NA; Mawela MP; Mphahlele MJ; Steele AD
Vaccine; 2012 Sep; 30 Suppl 3():C14-20. PubMed ID: 22939015
[TBL] [Abstract][Full Text] [Related]
15. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
[TBL] [Abstract][Full Text] [Related]
16. Update on Rotarix: an oral human rotavirus vaccine.
O'Ryan M; Linhares AC
Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccines in Belgium: policy and impact.
Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus vaccines at the threshold of implementation in India.
Tate JE; Arora R; Kang G; Parashar UD
Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421
[TBL] [Abstract][Full Text] [Related]
19. Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea.
Burnett E; Jonesteller CL; Tate JE; Yen C; Parashar UD
J Infect Dis; 2017 Jun; 215(11):1666-1672. PubMed ID: 28430997
[TBL] [Abstract][Full Text] [Related]
20. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
